1. CD44v6 expression is associated with a poor prognosis in Chinese hepatocellular carcinoma patients: A meta-analysis
   Yong Fu et al, 2015, Clinics and Research in Hepatology and Gastroenterology CrossRef
2. Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
   Yangkun Luo et al, 2016, Cancer Cell International CrossRef
3. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival
   Zhao-Shan Niu, 2015, World Journal of Hepatology CrossRef
4. CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus‐positive patients with resected hepatocellular carcinoma
   Anna Kakehashi et al, 2016, Cancer Science CrossRef
5. New trends in guided nanotherapies for digestive cancers: A systematic review
   Elisabete Fernandes et al, 2015, Journal of Controlled Release CrossRef